Healthpeak Properties (DOC) Financials

$17.36 +0.52 (+3.09%)

Closing price 05/27/2025 03:59 PM Eastern

Extended Trading

$17.23 -0.13 (-0.74%)

As of 07:13 AM Eastern

Annual Income Statements for Healthpeak Properties

This table shows Healthpeak Properties' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	242	304	498	502	411	44	1,058	413	627	-561
Consolidated Net Income / (Loss)	267	335	516	526	428	60	1,073	423	640	-546
Net Income / (Loss) Continuing Operations	267	335	514	138	161	175	837	423	374	153
Total Pre-Tax Income	273	315	507	128	218	176	839	410	367	136
Total Revenue	2,420	1,981	1,888	1,738	1,427	1,023	930	1,541	1,665	1,461
Net Interest Income / (Expense)	-236	-179	-150	-120	-202	-208	-251	-251	-376	-367
Total Interest Income	45	22	23	38	17	9.84	10	56	89	112
Investment Securities Interest Income	45	22	23	38	17	9.84	10	56	89	112
Total Interest Expense	280	200	173	158	218	218	261	308	464	480
Long-Term Debt Interest Expense	280	200	173	158	218	218	261	308	464	480
Total Non-Interest Income	2,656	2,159	2,038	1,858	1,628	1,230	1,181	1,792	2,040	1,828
Service Charges on Deposit Accounts	568	527	495	471	436	144	144	524	-	525
Other Non-Interest Income	2,087	1,632	1,543	1,387	1,192	1,086	1,037	1,268	2,040	1,303
Total Non-Interest Expense	2,385	1,759	1,716	1,581	1,491	953	892	1,464	1,420	1,347
Other Operating Expenses	1,172	997	994	872	876	498	475	755	842	707
Depreciation Expense	1,057	750	711	684	554	435	405	535	568	505
Impairment Charge	23	-5.60	7.00	23	43	18	11	166	0.00	108
Restructuring Charge	133	18	4.85	1.84	18	1.96	1.14	7.96	9.82	27
Nonoperating Income / (Expense), net	238	93	335	-29	282	107	801	334	122	23
Income Tax Expense	4.35	-9.62	-4.43	-3.26	-9.42	-5.48	-4.40	-1.33	4.47	-9.81
Other Gains / (Losses), net	-1.52	10	1.99	6.10	-67	-6.33	-5.76	11	11	6.59
Net Income / (Loss) Discontinued Operations	0.00	0.00	2.88	388	268	-115	236	-	266	-699
Net Income / (Loss) Attributable to Noncontrolling Interest	25	30	19	21	14	15	12	8.47	12	13
Basic Earnings per Share	$0.36	$0.56	$0.92	$0.93	$0.77	$0.09	$2.25	$0.88	$1.34	($1.21)
Weighted Average Basic Shares Outstanding	675.68M	547.01M	538.81M	538.93M	530.56M	486.26M	470.55M	468.76M	467.20M	462.80M
Diluted Earnings per Share	$0.36	$0.56	$0.92	$0.93	$0.77	$0.09	$2.24	$0.88	$1.34	($1.21)
Weighted Average Diluted Shares Outstanding	676.23M	547.28M	539.15M	539.24M	531.06M	489.34M	475.39M	468.94M	467.40M	462.80M
Weighted Average Basic & Diluted Shares Outstanding	699.56M	547.17M	546.78M	539.30M	538.69M	505.41M	470.40M	469.30M	467.60M	463.30M
Cash Dividends to Common per Share	$1.20	$1.20	$1.20	$1.20	$1.48	$1.48	$1.48	$1.48	$2.10	$2.26

This table shows Healthpeak Properties' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	10/31/2024	7/31/2024	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Net Income / (Loss) Attributable to Common Shareholders	-13	-26	42	4.40	86	146	6.48	71	64	52	118
Consolidated Net Income / (Loss)	-13	-26	50	11	93	153	11	75	69	56	135
Net Income / (Loss) Continuing Operations	-13	-26	50	11	93	153	11	75	69	56	135
Total Pre-Tax Income	-12	-26	54	-3.23	99	155	22	60	67	55	133
Total Operating Income	-30	-43	-	-	-	-	-	-	-	-	-
Total Gross Profit	144	135	-	-	-	-	-	-	-	-	-
Total Revenue	173	165	630	627	626	621	546	501	506	496	478
Operating Revenue	173	165	-	-	-	-	-	-	-	-	-
Total Cost of Revenue	30	30	-	-	-	-	-	-	-	-	-
Operating Cost of Revenue	30	30	-	-	-	-	-	-	-	-	-
Total Operating Expenses	173	178	-	-	-	-	-	-	-	-	-
Selling, General & Admin Expense	34	36	-	-	-	-	-	-	-	-	-
Marketing Expense	86	88	-	-	-	-	-	-	-	-	-
Research & Development Expense	53	55	-	-	-	-	-	-	-	-	-
Total Other Income / (Expense), net	17	17	-	-	-	-	-	-	-	-	-
Interest & Investment Income	17	18	16	17	14	7.83	5.75	4.98	5.36	5.28	6.16
Other Income / (Expense), net	0.10	-0.26	-	-	-	-	-	-	-	-	-
Income Tax Expense	0.61	0.65	2.08	-14	1.94	2.73	14	-12	0.79	1.14	0.30
Basic Earnings per Share	($0.06)	($0.13)	$0.06	$0.02	$0.12	$0.21	$0.01	$0.13	$0.12	$0.09	$0.22
Weighted Average Basic Shares Outstanding	203.53M	201.87M	699.07M	675.68M	699.35M	702.38M	600.90M	547.01M	547.06M	547.03M	546.84M
Diluted Earnings per Share	($0.06)	($0.13)	$0.06	$0.02	$0.12	$0.21	$0.01	$0.13	$0.12	$0.09	$0.22
Weighted Average Diluted Shares Outstanding	203.53M	201.87M	699.12M	676.23M	700.15M	703.27M	601.19M	547.28M	547.33M	547.29M	547.11M
Weighted Average Basic & Diluted Shares Outstanding	204.45M	202.89M	694.73M	699.56M	699.44M	699.29M	703.78M	547.17M	547.07M	547.05M	547.00M

This table details how cash moves in and out of Healthpeak Properties' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	15	42	-93	38	-2.97	45	58	-55	-270	174
Net Cash From Operating Activities	1,070	956	900	795	758	846	849	847	1,214	1,222
Net Cash From Continuing Operating Activities	1,070	956	900	795	758	846	849	847	1,214	1,228
Net Income / (Loss) Continuing Operations	267	335	516	526	428	60	1,073	423	640	-546
Consolidated Net Income / (Loss)	267	335	516	526	428	60	1,073	423	640	-546
Depreciation Expense	1,057	750	711	684	697	660	549	535	573	511
Amortization Expense	-91	-97	-92	-85	-72	11	13	15	20	20
Non-Cash Adjustments to Reconcile Net Income	-208	-114	-354	-356	-404	93	-833	-105	-54	1,296
Changes in Operating Assets and Liabilities, net	45	83	119	26	109	22	46	-20	35	-53
Net Cash From Investing Activities	-114	-577	-876	531	-1,008	-1,449	1,829	1,246	-429	-1,660
Net Cash From Continuing Investing Activities	-114	-577	-876	531	-1,008	-1,449	1,829	1,246	-429	-1,660
Purchase of Property, Leasehold Improvements and Equipment	-116	-114	-109	-111	-94	-109	-106	-115	-91	-84
Purchase of Investment Securities	-592	-855	-1,072	-2,137	-2,441	-2,326	-587	-1,011	-1,246	-2,308
Sale and/or Maturity of Investments	751	371	291	2,742	1,509	514	2,528	2,335	232	628
Other Investing Activities, net	-156	21	13	38	19	382	26	37	28	31
Net Cash From Financing Activities	-941	-337	-117	-1,289	246	647	-2,621	-2,148	-1,054	614
Net Cash From Continuing Financing Activities	-941	-337	-117	-1,289	246	647	-2,621	-2,148	-1,054	614
Issuance of Debt	4,491	11,088	16,382	17,910	5,337	9,905	2,047	1,250	2,794	2,368
Issuance of Common Equity	0.32	0.28	308	5.04	1,069	796	517	28	68	206
Repayment of Debt	-4,358	-10,718	-16,062	-18,448	-5,322	-9,332	-4,401	-2,670	-2,912	-989
Repurchase of Common Equity	-191	-6.52	-68	-13	-11	-5.04	-3.43	-4.79	-8.69	-8.74
Payment of Dividends	-795	-657	-648	-650	-787	-720	-697	-695	-980	-1,047
Other Financing Activities, Net	-90	-45	-29	-93	-41	3.80	-83	-56	-16	85

This table details how cash moves in and out of Healthpeak Properties' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	10/31/2024	7/31/2024	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Net Change in Cash & Equivalents	126	202	-46	-58	83	2.14	-12	55	-47	43	-9.61
Net Cash From Operating Activities	38	-8.57	279	284	318	316	153	231	253	298	174
Net Cash From Continuing Operating Activities	38	-8.57	279	284	318	316	153	231	253	298	174
Net Income / (Loss) Continuing Operations	-13	-26	50	11	93	153	11	75	69	56	135
Consolidated Net Income / (Loss)	-13	-26	50	11	93	153	11	75	69	56	135
Depreciation Expense	3.47	3.32	269	274	280	283	219	189	185	198	179
Amortization Expense	-3.13	-3.55	-26	-21	-23	-22	-24	-25	-23	-26	-23
Non-Cash Adjustments To Reconcile Net Income	39	39	3.69	29	-61	-125	-52	-22	-5.44	-6.00	-81
Changes in Operating Assets and Liabilities, net	12	-21	-17	-9.50	29	27	-1.75	14	29	76	-36
Net Cash From Investing Activities	91	203	-231	-234	30	188	-98	-216	-222	-195	56
Net Cash From Continuing Investing Activities	91	203	-231	-234	30	188	-98	-216	-222	-195	56
Purchase of Property, Plant & Equipment	-2.44	-2.63	-23	-39	-24	-36	-18	-47	-24	-19	-23
Purchase of Investments	-47	-126	-280	-109	-205	-139	-140	-199	-214	-216	-227
Sale and/or Maturity of Investments	140	332	65	-89	254	354	232	25	6.76	38	303
Net Cash From Financing Activities	-2.33	7.63	-94	-107	-266	-502	-67	40	-77	-60	-240
Net Cash From Continuing Financing Activities	-2.33	7.63	-94	-107	-266	-502	-67	40	-77	-60	-240
Other Financing Activities, net	-2.33	0.96	-10	-9.34	-9.72	-63	-7.25	-6.74	-7.14	-8.20	-23
Cash Income Taxes Paid	0.97	0.52	-	-	-	-	-	-	-	-	-

This table presents Healthpeak Properties' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	19,938	15,699	15,771	15,258	15,920	14,033	12,719	14,088	15,759	21,450
Cash and Due from Banks	120	118	72	158	44	80	111	55	95	340
Restricted Cash	64	51	55	53	67	13	29	27	42	46
Loans and Leases, Net of Allowance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Premises and Equipment, Net	15,831	13,028	13,023	12,667	11,120	8,231	10,209	10,732	11,326	11,854
Intangible Assets	817	314	418	520	520	260	305	410	480	587
Other Assets	3,105	2,187	2,203	1,859	3,974	5,448	2,001	2,864	3,009	8,622
Total Liabilities & Shareholders' Equity	19,938	15,699	15,771	15,258	15,920	14,033	12,719	14,088	15,759	21,450
Total Liabilities	10,881	8,774	8,483	8,111	8,573	7,365	6,206	8,494	9,818	11,704
Short-Term Debt	150	720	996	1,166	-	93	91	94	92	94
Other Short-Term Payables	725	657	-	-	761	-	392	402	417	431
Long-Term Debt	8,566	6,156	5,502	5,004	6,298	5,909	5,477	7,786	9,097	10,975
Other Long-Term Liabilities	1,439	1,240	1,985	1,941	1,514	1,363	246	211	211	204
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	2.61	49	106	87	57	-	-	-	-	-
Total Equity & Noncontrolling Interests	9,055	6,876	7,183	7,059	7,290	6,667	6,513	5,595	5,941	9,746
Total Preferred & Common Equity	8,401	6,350	6,655	6,515	6,734	6,085	5,944	5,301	5,548	9,344
Total Common Equity	8,401	6,350	6,655	6,515	6,734	6,085	5,944	5,301	5,548	9,344
Common Stock	13,547	10,953	10,896	10,639	10,714	9,689	8,876	8,696	8,667	12,113
Accumulated Other Comprehensive Income / (Loss)	29	19	28	-3.15	-3.69	-2.86	-4.71	-24	-30	-30
Other Equity Adjustments	-5,174	-4,622	-	-	-	-	-2,927	-	-	-
Noncontrolling Interest	654	526	528	543	556	582	568	294	394	403

This table presents Healthpeak Properties' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	10/31/2024	7/31/2024	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Total Assets	1,693	1,679	19,816	19,938	19,970	20,180	20,542	15,699	15,603	15,604	15,602
Total Current Assets	1,553	1,536	-	-	-	-	-	-	-	-	-
Cash & Equivalents	924	797	71	120	180	107	102	118	63	104	59
Short-Term Investments	423	512	-	-	-	-	-	-	-	-	-
Accounts Receivable	129	148	-	-	-	-	-	-	-	-	-
Prepaid Expenses	26	28	-	-	-	-	-	-	-	-	-
Other Current Assets	51	50	-	-	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	0.00	0.00	-	-	-	-	-	-	-	-	-
Total Noncurrent Assets	140	143	-	-	-	-	-	-	-	-	-
Goodwill	12	12	-	-	-	-	-	-	-	-	-
Intangible Assets	9.49	10	748	817	898	1,076	1,160	314	339	364	392
Other Noncurrent Operating Assets	118	121	-	-	-	-	-	-	-	-	-
Total Liabilities & Shareholders' Equity	1,693	1,679	19,816	19,938	19,970	20,180	20,542	15,699	15,603	15,604	15,602
Total Liabilities	435	445	10,972	10,881	10,748	10,761	10,943	8,774	8,570	8,478	8,379
Total Current Liabilities	410	414	-	-	-	-	-	-	-	-	-
Accounts Payable	21	13	-	-	-	-	-	-	-	-	-
Accrued Expenses	14	19	-	-	-	-	-	-	-	-	-
Customer Deposits	20	22	-	-	-	-	-	-	-	-	-
Current Deferred Revenue	310	311	-	-	-	-	-	-	-	-	-
Current Employee Benefit Liabilities	44	49	-	-	-	-	-	-	-	-	-
Total Noncurrent Liabilities	25	31	-	-	-	-	-	-	-	-	-
Noncurrent Deferred Revenue	17	21	-	-	-	-	-	-	-	-	-
Other Noncurrent Operating Liabilities	8.55	9.39	-	-	-	-	-	-	-	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,258	1,234	8,829	9,055	9,221	9,417	9,545	6,876	6,984	7,062	7,138
Total Preferred & Common Equity	1,258	1,234	8,188	8,401	8,563	8,757	8,882	6,350	6,457	6,535	6,610
Total Common Equity	1,258	1,234	8,188	8,401	8,563	8,757	8,882	6,350	6,457	6,535	6,610
Common Stock	2,319	2,283	13,526	13,547	13,544	13,560	13,623	10,953	10,949	10,932	10,907
Retained Earnings	-1,062	-1,049	-5,345	-	-	-	-4,780	-	-	-	-
Accumulated Other Comprehensive Income / (Loss)	0.38	-0.02	6.93	29	-12	42	39	19	37	31	19

This table displays calculated financial ratios and metrics derived from Healthpeak Properties' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	22.18%	4.90%	8.63%	21.85%	39.48%	9.97%	-39.63%	-7.46%	13.96%	22.04%
EBITDA Growth	14.53%	10.63%	4.50%	34.86%	-24.25%	23.41%	-4.12%	-25.31%	29.98%	-12.90%
EBIT Growth	-84.15%	29.04%	9.18%	344.16%	-192.51%	83.56%	-50.44%	-68.74%	115.46%	-56.59%
NOPAT Growth	-84.87%	31.83%	7.41%	339.98%	-193.61%	88.28%	-50.34%	-68.25%	98.55%	-53.55%
Net Income Growth	-20.15%	-35.18%	-1.81%	22.81%	613.03%	-94.41%	154.00%	-33.96%	217.11%	-158.34%
EPS Growth	-35.71%	-39.13%	-1.08%	20.78%	755.56%	-95.98%	154.55%	-34.33%	210.74%	-158.34%
Operating Cash Flow Growth	11.95%	6.22%	13.21%	4.85%	-10.36%	-0.31%	0.20%	-30.23%	-0.66%	-2.12%
Free Cash Flow Firm Growth	-1,947.45%	171.89%	-160.44%	147.04%	-101.55%	-136.11%	-17.27%	-70.77%	23,686.22%	102.89%
Invested Capital Growth	28.78%	0.11%	3.53%	-2.41%	7.70%	4.88%	-10.35%	-10.94%	-27.31%	0.47%
Revenue Q/Q Growth	5.52%	1.32%	1.53%	4.14%	84.44%	15.31%	-45.70%	-4.07%	42.21%	6.07%
EBITDA Q/Q Growth	6.58%	6.78%	-1.67%	7.31%	-19.01%	45.38%	-5.75%	-20.04%	-2.68%	445.54%
EBIT Q/Q Growth	-43.95%	26.48%	-7.10%	25.11%	-821.84%	168.54%	-44.10%	-65.49%	-10.10%	129.40%
NOPAT Q/Q Growth	-43.75%	31.12%	-7.29%	23.31%	-851.75%	170.60%	-44.47%	-66.10%	-11.65%	145.02%
Net Income Q/Q Growth	-19.49%	23.91%	-4.05%	-18.28%	31.62%	-92.91%	492.53%	-22.00%	4,101.79%	-320.48%
EPS Q/Q Growth	-23.40%	27.27%	-4.17%	-18.42%	30.51%	-94.67%	522.22%	-22.12%	2,014.29%	-320.48%
Operating Cash Flow Q/Q Growth	5.13%	2.61%	-1.85%	0.66%	0.16%	0.20%	0.79%	-0.74%	-10.27%	-0.90%
Free Cash Flow Firm Q/Q Growth	2.69%	9.71%	54.64%	-52.84%	-59.58%	34.25%	50.77%	-76.60%	328.45%	101.53%
Invested Capital Q/Q Growth	-0.18%	0.76%	0.50%	3.41%	-1.02%	-3.46%	-2.88%	1.16%	-26.18%	-3.66%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	41.39%	44.15%	41.86%	43.52%	39.32%	72.41%	64.52%	40.62%	50.33%	44.13%
EBIT Margin	1.45%	11.19%	9.10%	9.05%	-4.52%	6.81%	4.08%	4.97%	14.71%	7.78%
Profit (Net Income) Margin	11.05%	16.90%	27.35%	30.26%	30.02%	5.87%	115.42%	27.43%	38.44%	-37.40%
Tax Burden Percent	97.85%	106.29%	101.83%	409.71%	196.73%	34.06%	128.01%	102.98%	174.23%	-400.98%
Interest Burden Percent	777.64%	142.08%	295.21%	81.59%	-337.81%	253.13%	2,209.92%	536.01%	149.94%	119.87%
Effective Tax Rate	1.59%	-3.05%	-0.87%	-2.54%	-4.33%	-3.11%	-0.52%	-0.32%	1.22%	-7.20%
Return on Invested Capital (ROIC)	0.22%	1.66%	1.28%	1.20%	-0.51%	0.58%	0.30%	0.54%	1.35%	0.59%
ROIC Less NNEP Spread (ROIC-NNEP)	3.20%	3.25%	6.70%	7.05%	7.55%	0.38%	15.70%	4.59%	5.28%	-5.84%
Return on Net Nonoperating Assets (RNNOA)	3.13%	3.05%	5.88%	6.06%	6.62%	0.33%	17.43%	6.79%	6.81%	-5.86%
Return on Equity (ROE)	3.34%	4.71%	7.16%	7.26%	6.11%	0.91%	17.73%	7.33%	8.16%	-5.27%
Cash Return on Invested Capital (CROIC)	-24.94%	1.55%	-2.19%	3.64%	-7.93%	-4.18%	11.22%	12.11%	32.97%	0.12%
Operating Return on Assets (OROA)	0.20%	1.41%	1.11%	1.01%	-0.43%	0.52%	0.28%	0.51%	1.32%	0.53%
Return on Assets (ROA)	1.50%	2.13%	3.33%	3.37%	2.86%	0.45%	8.01%	2.83%	3.44%	-2.55%
Return on Common Equity (ROCE)	3.09%	4.31%	6.53%	6.63%	5.59%	0.83%	16.47%	6.89%	7.74%	-5.10%
Return on Equity Simple (ROE_SIMPLE)	3.18%	5.27%	7.76%	8.07%	6.36%	0.99%	18.06%	7.97%	11.54%	-5.85%
Net Operating Profit after Tax (NOPAT)	35	228	173	161	-67	72	38	77	242	122
NOPAT Margin	1.43%	11.53%	9.18%	9.28%	-4.71%	7.02%	4.10%	4.99%	14.53%	8.34%
Net Nonoperating Expense Percent (NNEP)	-2.99%	-1.59%	-5.42%	-5.85%	-8.06%	0.20%	-15.40%	-4.05%	-3.93%	6.43%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	98.55%	88.81%	90.90%	90.95%	104.52%	93.19%	95.92%	95.03%	85.29%	92.22%
Earnings before Interest and Taxes (EBIT)	35	222	172	157	-64	70	38	77	245	114
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,002	874	790	756	561	741	600	626	838	645
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.66	1.58	1.77	2.51	1.96	2.16	1.62	1.60	1.80	1.18
Price to Tangible Book Value (P/TBV)	1.84	1.66	1.89	2.72	2.12	2.25	1.71	1.73	1.98	1.26
Price to Revenue (P/Rev)	5.77	5.07	6.25	9.39	9.24	12.83	10.37	5.50	6.01	7.55
Price to Earnings (P/E)	57.60	32.99	23.70	32.50	32.05	298.30	9.11	20.51	15.98	0.00
Dividend Yield	6.01%	6.54%	5.47%	3.96%	6.05%	5.58%	7.21%	8.20%	9.96%	9.53%
Earnings Yield	1.74%	3.03%	4.22%	3.08%	3.12%	0.34%	10.97%	4.88%	6.26%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.30	1.25	1.36	1.72	1.46	1.55	1.29	1.23	1.29	1.06
Enterprise Value to Revenue (EV/Rev)	9.57	8.74	9.96	13.18	14.00	19.18	16.82	10.75	11.69	15.14
Enterprise Value to EBITDA (EV/EBITDA)	23.11	19.80	23.79	30.29	35.61	26.48	26.07	26.46	23.22	34.30
Enterprise Value to EBIT (EV/EBIT)	659.00	78.13	109.45	145.64	0.00	281.56	412.22	216.31	79.43	194.53
Enterprise Value to NOPAT (EV/NOPAT)	669.66	75.82	108.50	142.03	0.00	273.08	410.07	215.61	80.41	181.47
Enterprise Value to Operating Cash Flow (EV/OCF)	21.62	18.11	20.89	28.81	26.34	23.18	18.43	19.55	16.03	18.10
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	81.25	0.00	46.71	0.00	0.00	10.92	9.56	3.28	887.61
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.96	0.99	0.89	0.86	0.86	0.90	0.85	1.41	1.55	1.14
Long-Term Debt to Equity	0.95	0.89	0.75	0.70	0.86	0.89	0.84	1.39	1.53	1.13
Financial Leverage	0.98	0.94	0.88	0.86	0.88	0.88	1.11	1.48	1.29	1.00
Leverage Ratio	2.23	2.21	2.15	2.15	2.14	2.03	2.21	2.59	2.37	2.06
Compound Leverage Factor	17.34	3.15	6.35	1.76	-7.22	5.14	48.93	13.87	3.56	2.47
Debt to Total Capital	49.04%	49.82%	47.13%	46.33%	46.15%	47.37%	46.09%	58.48%	60.73%	53.18%
Short-Term Debt to Total Capital	0.84%	5.22%	7.22%	8.76%	0.00%	0.73%	0.75%	0.70%	0.61%	0.45%
Long-Term Debt to Total Capital	48.20%	44.61%	39.91%	37.58%	46.15%	46.64%	45.34%	57.78%	60.12%	52.72%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.69%	4.16%	4.60%	4.74%	4.50%	4.60%	4.70%	2.18%	2.60%	1.93%
Common Equity to Total Capital	47.27%	46.01%	48.27%	48.93%	49.35%	48.03%	49.21%	39.34%	36.66%	44.89%
Debt to EBITDA	8.70	7.86	8.22	8.16	11.23	8.11	9.28	12.59	10.97	17.17
Net Debt to EBITDA	8.52	7.67	8.06	7.88	11.03	7.98	9.05	12.46	10.80	16.57
Long-Term Debt to EBITDA	8.55	7.04	6.96	6.61	11.23	7.98	9.13	12.44	10.86	17.02
Debt to NOPAT	252.14	30.10	37.50	38.24	-93.68	83.57	145.97	102.59	37.98	90.83
Net Debt to NOPAT	246.81	29.36	36.77	36.93	-92.02	82.27	142.30	101.52	37.41	87.66
Long-Term Debt to NOPAT	247.80	26.95	31.75	31.02	-93.68	82.28	143.59	101.36	37.60	90.05
Noncontrolling Interest Sharing Ratio	7.70%	8.50%	8.76%	8.59%	8.53%	8.73%	7.12%	5.96%	5.08%	3.20%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3,938	213	-297	491	-1,043	-517	1,433	1,732	5,926	25
Operating Cash Flow to CapEx	924.56%	841.79%	829.66%	713.35%	805.80%	777.33%	799.21%	734.90%	0.00%	10,977.68%
Free Cash Flow to Firm to Interest Expense	-14.04	1.06	-1.71	3.11	-4.78	-2.38	5.48	5.63	12.76	0.05
Operating Cash Flow to Interest Expense	3.82	4.77	5.21	5.03	3.47	3.89	3.25	2.75	2.61	2.55
Operating Cash Flow Less CapEx to Interest Expense	3.40	4.21	4.58	4.33	3.04	3.39	2.84	2.38	3.81	2.53
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.14	0.13	0.12	0.11	0.10	0.08	0.07	0.10	0.09	0.07
Fixed Asset Turnover	0.17	0.15	0.15	0.15	0.15	0.11	0.09	0.14	0.14	0.13
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	17,774	13,801	13,786	13,316	13,645	12,670	12,080	13,475	15,131	20,815
Invested Capital Turnover	0.15	0.14	0.14	0.13	0.11	0.08	0.07	0.11	0.09	0.07
Increase / (Decrease) in Invested Capital	3,973	15	470	-329	976	589	-1,395	-1,655	-5,685	97
Enterprise Value (EV)	23,149	17,319	18,802	22,914	19,976	19,612	15,642	16,562	19,456	22,115
Market Capitalization	13,961	10,037	11,798	16,325	13,176	13,121	9,646	8,470	10,010	11,030
Book Value per Share	$12.01	$11.61	$12.38	$12.09	$12.51	$12.29	$12.65	$11.30	$11.85	$20.09
Tangible Book Value per Share	$10.84	$11.03	$11.60	$11.12	$11.54	$11.77	$12.00	$10.43	$10.83	$18.83
Total Capital	17,774	13,801	13,786	13,316	13,645	12,670	12,080	13,475	15,131	20,815
Total Debt	8,716	6,876	6,498	6,170	6,298	6,002	5,568	7,880	9,189	11,069
Total Long-Term Debt	8,566	6,156	5,502	5,004	6,298	5,909	5,477	7,786	9,097	10,975
Net Debt	8,532	6,707	6,371	5,958	6,187	5,908	5,428	7,798	9,053	10,682
Capital Expenditures (CapEx)	116	114	109	111	94	109	106	115	-556	11
Net Nonoperating Expense (NNE)	-233	-106	-343	-365	-495	12	-1,035	-346	-398	668
Net Nonoperating Obligations (NNO)	8,716	6,876	6,498	6,170	6,298	6,002	5,568	7,880	9,189	11,069
Total Depreciation and Amortization (D&A)	966	653	619	599	625	671	562	549	593	531
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.36	$0.56	$0.92	$0.93	$0.77	$0.09	$2.25	$0.88	$1.34	($1.11)
Adjusted Weighted Average Basic Shares Outstanding	675.68M	547.01M	538.81M	538.93M	530.56M	486.26M	470.55M	468.76M	467.20M	506.09M
Adjusted Diluted Earnings per Share	$0.36	$0.56	$0.92	$0.93	$0.77	$0.09	$2.24	$0.88	$1.34	($1.11)
Adjusted Weighted Average Diluted Shares Outstanding	676.23M	547.28M	539.15M	539.24M	531.06M	489.34M	475.39M	468.94M	467.40M	506.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.09	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	699.56M	547.17M	546.78M	539.30M	538.69M	505.41M	477.77M	469.44M	468.18M	509.08M
Normalized Net Operating Profit after Tax (NOPAT)	188	164	129	128	-2.23	63	35	176	252	175
Normalized NOPAT Margin	7.76%	8.26%	6.81%	7.34%	-0.16%	6.11%	3.76%	11.40%	15.12%	11.95%
Pre Tax Income Margin	11.29%	15.90%	26.86%	7.39%	15.26%	17.24%	90.17%	26.64%	22.06%	9.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.13	1.11	0.99	1.00	-0.30	0.32	0.15	0.25	0.53	0.24
NOPAT to Interest Expense	0.12	1.14	1.00	1.02	-0.31	0.33	0.15	0.25	0.52	0.25
EBIT Less CapEx to Interest Expense	-0.29	0.54	0.37	0.29	-0.73	-0.18	-0.26	-0.13	1.73	0.21
NOPAT Less CapEx to Interest Expense	-0.29	0.57	0.37	0.32	-0.74	-0.17	-0.26	-0.12	1.72	0.23
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	297.33%	196.27%	125.49%	123.61%	183.79%	1,198.99%	64.92%	164.43%	153.07%	-191.55%
Augmented Payout Ratio	368.67%	198.22%	138.62%	126.05%	186.25%	1,207.38%	65.24%	165.57%	154.43%	-193.14%

This table displays calculated financial ratios and metrics derived from Healthpeak Properties' official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	10/31/2024	7/31/2024	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	18.66%	15.28%	15.49%	25.28%	23.84%	25.03%	14.22%	5.43%	6.17%	4.26%	3.67%
EBITDA Growth	48.86%	47.41%	123.25%	27.92%	28.67%	32.68%	-34.52%	33.49%	10.99%	2.92%	-0.12%
EBIT Growth	46.80%	47.33%	201.93%	-47.99%	-46.55%	-38.57%	-217.04%	422.20%	21.41%	-13.15%	-1.75%
NOPAT Growth	46.23%	47.58%	350.60%	-69.59%	-46.98%	-38.36%	-145.89%	484.97%	18.71%	-15.85%	-0.93%
Net Income Growth	67.05%	60.10%	347.92%	-85.85%	35.08%	171.74%	-91.69%	597.97%	-80.82%	-22.26%	78.53%
EPS Growth	70.00%	61.76%	500.00%	-84.62%	0.00%	133.33%	-95.45%	1,200.00%	-81.54%	-30.77%	69.23%
Operating Cash Flow Growth	340.88%	74.54%	83.16%	22.61%	25.64%	6.17%	-12.28%	11.74%	3.95%	16.57%	-10.43%
Free Cash Flow Firm Growth	109.12%	76.50%	114.75%	-7,493.81%	-4,882.92%	-1,709.83%	-1,812.59%	111.67%	110.84%	73.08%	1.86%
Invested Capital Growth	-38.81%	-27.29%	-3.46%	28.78%	29.99%	31.60%	34.20%	0.11%	-0.15%	2.12%	2.21%
Revenue Q/Q Growth	5.00%	2.84%	0.43%	0.19%	0.92%	13.73%	8.94%	-0.96%	1.89%	3.90%	0.56%
EBITDA Q/Q Growth	32.76%	35.70%	6.84%	-3.05%	0.50%	114.45%	-38.78%	-2.48%	3.63%	5.83%	24.81%
EBIT Q/Q Growth	31.62%	35.64%	102.39%	-15.20%	19.96%	149.51%	-203.27%	-12.85%	37.88%	-5.68%	360.77%
NOPAT Q/Q Growth	30.99%	36.06%	178.05%	-39.45%	19.70%	224.34%	-133.74%	5.58%	39.17%	-7.43%	330.09%
Net Income Q/Q Growth	50.85%	48.24%	369.12%	-88.49%	-39.27%	1,266.34%	-85.18%	9.82%	22.17%	-58.22%	1,145.20%
EPS Q/Q Growth	53.85%	50.00%	200.00%	-83.33%	-42.86%	2,000.00%	-92.31%	8.33%	33.33%	-59.09%	2,100.00%
Operating Cash Flow Q/Q Growth	545.25%	-130.45%	-1.45%	-10.90%	0.63%	107.26%	-34.03%	-8.69%	-14.96%	71.24%	-15.96%
Free Cash Flow Firm Q/Q Growth	127.49%	69.26%	117.55%	3.00%	5.24%	8.56%	-8,895.93%	-37.25%	135.86%	3.37%	46.34%
Invested Capital Q/Q Growth	-17.75%	21.71%	-0.30%	-0.18%	-1.20%	-1.82%	33.00%	0.76%	0.02%	0.12%	-0.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	82.82%	81.71%	-	-	-	-	-	-	-	-	-
EBITDA Margin	-16.98%	-26.52%	48.02%	45.14%	46.64%	46.84%	24.84%	44.20%	44.89%	44.14%	43.33%
Operating Margin	-17.23%	-26.22%	-	-	-	-	-	-	-	-	-
EBIT Margin	-17.18%	-26.38%	9.59%	4.76%	5.62%	4.73%	-10.86%	11.46%	13.02%	9.62%	10.60%
Profit (Net Income) Margin	-7.50%	-16.02%	7.94%	1.70%	14.81%	24.61%	2.05%	15.05%	13.58%	11.32%	28.16%
Tax Burden Percent	104.93%	102.52%	92.21%	-329.99%	94.14%	98.28%	49.68%	125.67%	101.95%	102.92%	101.14%
Interest Burden Percent	41.62%	59.26%	89.86%	-10.83%	279.83%	529.54%	-37.96%	104.53%	102.25%	114.32%	262.61%
Effective Tax Rate	0.00%	0.00%	3.83%	0.00%	1.97%	1.76%	60.88%	-19.74%	1.17%	2.08%	0.23%
Return on Invested Capital (ROIC)	0.00%	0.00%	1.28%	0.51%	0.80%	0.64%	-0.54%	1.97%	1.84%	1.34%	1.49%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	1.19%	0.38%	1.57%	2.27%	-0.09%	2.07%	1.89%	1.48%	2.80%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	1.14%	0.37%	1.47%	2.08%	-0.08%	1.95%	1.77%	1.37%	2.51%
Return on Equity (ROE)	-9.98%	-12.29%	2.42%	0.88%	2.27%	2.72%	-0.63%	3.92%	3.60%	2.71%	4.00%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	4.40%	-24.94%	-25.69%	-26.71%	-28.52%	1.55%	1.42%	-0.88%	-0.92%
Operating Return on Assets (OROA)	-6.86%	-10.13%	1.19%	0.65%	0.72%	0.57%	-1.23%	1.44%	1.63%	1.20%	1.31%
Return on Assets (ROA)	-3.00%	-6.15%	0.99%	0.23%	1.91%	2.99%	0.23%	1.89%	1.70%	1.41%	3.47%
Return on Common Equity (ROCE)	-9.98%	-12.29%	2.24%	0.81%	2.10%	2.51%	-0.58%	3.59%	3.29%	2.47%	3.65%
Return on Equity Simple (ROE_SIMPLE)	-9.72%	-12.05%	3.74%	0.00%	3.88%	3.52%	2.38%	0.00%	4.18%	8.56%	8.71%
Net Operating Profit after Tax (NOPAT)	-21	-30	58	21	35	29	-23	69	65	47	51
NOPAT Margin	-12.06%	-18.35%	9.22%	3.33%	5.51%	4.65%	-4.25%	13.72%	12.87%	9.42%	10.58%
Net Nonoperating Expense Percent (NNEP)	0.61%	0.30%	0.09%	0.13%	-0.76%	-1.63%	-0.45%	-0.10%	-0.05%	-0.14%	-1.31%
Cost of Revenue to Revenue	17.18%	18.29%	-	-	-	-	-	-	-	-	-
SG&A Expenses to Revenue	19.43%	21.57%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	30.78%	33.29%	-	-	-	-	-	-	-	-	-
Operating Expenses to Revenue	100.05%	107.93%	90.41%	95.24%	94.38%	95.27%	110.86%	88.54%	86.98%	90.38%	89.40%
Earnings before Interest and Taxes (EBIT)	-30	-44	60	30	35	29	-59	57	66	48	51
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-29	-44	303	283	292	291	136	221	227	219	207
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.46	5.50	1.72	1.66	1.81	1.51	1.09	1.58	1.42	1.51	1.61
Price to Tangible Book Value (P/TBV)	5.56	5.60	1.89	1.84	2.03	1.72	1.25	1.66	1.49	1.60	1.71
Price to Revenue (P/Rev)	10.49	10.81	5.62	5.77	6.77	6.08	4.72	5.07	4.68	5.13	5.58
Price to Earnings (P/E)	0.00	0.00	50.55	57.60	50.31	46.01	50.09	32.99	38.07	18.64	19.48
Dividend Yield	0.00%	0.00%	5.99%	6.01%	5.40%	6.39%	6.79%	6.54%	7.18%	6.65%	6.17%
Earnings Yield	0.00%	0.00%	1.98%	1.74%	1.99%	2.17%	2.00%	3.03%	2.63%	5.36%	5.13%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	1.32	1.30	1.38	1.24	1.03	1.25	1.19	1.23	1.29
Enterprise Value to Revenue (EV/Rev)	8.43	8.72	9.37	9.57	10.70	10.27	9.27	8.74	8.32	8.76	9.23
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	20.08	23.11	26.11	25.51	23.64	19.80	19.87	21.18	22.25
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	151.54	659.00	391.47	239.11	169.91	78.13	92.84	103.09	102.90
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	148.01	669.66	399.21	243.40	173.11	75.82	93.39	102.52	102.02
Enterprise Value to Operating Cash Flow (EV/OCF)	81.19	142.16	19.59	21.62	24.10	23.41	20.31	18.11	17.46	18.29	19.98
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	29.56	0.00	0.00	0.00	0.00	81.25	83.74	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	1.00	0.96	0.93	0.91	0.91	0.99	0.95	0.92	0.89
Long-Term Debt to Equity	0.00	0.00	0.99	0.95	0.93	0.91	0.89	0.89	0.89	0.88	0.82
Financial Leverage	-1.06	-1.06	0.96	0.98	0.94	0.92	0.90	0.94	0.94	0.92	0.90
Leverage Ratio	1.34	1.35	2.19	2.23	2.19	2.16	2.15	2.21	2.21	2.20	2.16
Compound Leverage Factor	0.56	0.80	1.97	-0.24	6.12	11.45	-0.82	2.31	2.26	2.51	5.68
Debt to Total Capital	0.00%	0.00%	50.09%	49.04%	48.21%	47.74%	47.70%	49.82%	48.66%	47.97%	47.19%
Short-Term Debt to Total Capital	0.00%	0.00%	0.93%	0.84%	0.00%	0.14%	1.00%	5.22%	3.10%	2.40%	4.07%
Long-Term Debt to Total Capital	0.00%	0.00%	49.17%	48.20%	48.21%	47.60%	46.70%	44.61%	45.56%	45.56%	43.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	3.70%	3.69%	3.70%	3.67%	3.91%	4.16%	4.20%	4.31%	4.49%
Common Equity to Total Capital	100.00%	100.00%	46.21%	47.27%	48.09%	48.59%	48.39%	46.01%	47.14%	47.72%	48.33%
Debt to EBITDA	0.00	0.00	7.60	8.70	9.13	9.84	10.90	7.86	8.14	8.25	8.17
Net Debt to EBITDA	0.00	0.00	7.48	8.52	8.88	9.65	10.71	7.67	8.00	8.05	8.02
Long-Term Debt to EBITDA	0.00	0.00	7.46	8.55	9.13	9.81	10.68	7.04	7.62	7.83	7.46
Debt to NOPAT	0.00	0.00	56.00	252.14	139.67	93.83	79.83	30.10	38.25	39.92	37.44
Net Debt to NOPAT	0.00	0.00	55.13	246.81	135.73	92.09	78.39	29.36	37.60	38.94	36.76
Long-Term Debt to NOPAT	0.00	0.00	54.97	247.80	139.67	93.56	78.16	26.95	35.82	37.92	34.22
Altman Z-Score	9.73	9.37	-	-	-	-	-	-	-	-	-
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	7.45%	7.70%	7.60%	7.57%	7.92%	8.50%	8.72%	8.82%	8.77%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.79	3.71	-	-	-	-	-	-	-	-	-
Quick Ratio	3.60	3.52	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	3.89	-14	693	-3,952	-4,074	-4,299	-4,701	53	85	-238	-246
Operating Cash Flow to CapEx	1,562.94%	-325.81%	1,207.77%	726.26%	1,353.53%	885.27%	870.95%	488.57%	1,053.88%	1,531.66%	763.18%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	9.54	-56.04	-54.97	-57.38	-77.18	1.01	1.69	-4.84	-5.12
Operating Cash Flow to Interest Expense	0.00	0.00	3.84	4.02	4.29	4.22	2.50	4.38	5.01	6.07	3.63
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	3.53	3.47	3.98	3.74	2.22	3.48	4.54	5.67	3.15
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.40	0.38	0.12	0.14	0.13	0.12	0.11	0.13	0.13	0.12	0.12
Accounts Receivable Turnover	5.51	4.65	-	-	-	-	-	-	-	-	-
Inventory Turnover	0.00	0.00	-	-	-	-	-	-	-	-	-
Fixed Asset Turnover	0.00	0.00	0.15	0.17	0.16	0.15	0.14	0.15	0.15	0.15	0.15
Accounts Payable Turnover	8.64	10.99	-	-	-	-	-	-	-	-	-
Days Sales Outstanding (DSO)	66.19	78.55	-	-	-	-	-	-	-	-	-
Days Inventory Outstanding (DIO)	0.00	0.00	-	-	-	-	-	-	-	-	-
Days Payable Outstanding (DPO)	42.27	33.20	-	-	-	-	-	-	-	-	-
Cash Conversion Cycle (CCC)	23.93	45.35	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-89	-75	17,720	17,774	17,805	18,022	18,355	13,801	13,697	13,694	13,678
Invested Capital Turnover	-8.58	-9.33	0.14	0.15	0.15	0.14	0.13	0.14	0.14	0.14	0.14
Increase / (Decrease) in Invested Capital	-25	-16	-635	3,973	4,108	4,327	4,678	15	-20	284	296
Enterprise Value (EV)	5,524	5,476	23,461	23,149	24,534	22,316	18,987	17,319	16,271	16,870	17,584
Market Capitalization	6,870	6,785	14,068	13,961	15,534	13,211	9,671	10,037	9,145	9,871	10,634
Book Value per Share	$6.20	$6.14	$11.70	$12.01	$12.25	$12.44	$14.78	$11.61	$11.80	$11.95	$12.09
Tangible Book Value per Share	$6.09	$6.03	$10.64	$10.84	$10.96	$10.91	$12.85	$11.03	$11.18	$11.28	$11.37
Total Capital	1,258	1,234	17,720	17,774	17,805	18,022	18,355	13,801	13,697	13,694	13,678
Total Debt	0.00	0.00	8,877	8,716	8,583	8,603	8,756	6,876	6,664	6,569	6,454
Total Long-Term Debt	0.00	0.00	8,713	8,566	8,583	8,578	8,573	6,156	6,240	6,240	5,898
Net Debt	-1,346	-1,309	8,738	8,532	8,341	8,444	8,599	6,707	6,550	6,408	6,337
Capital Expenditures (CapEx)	2.44	2.63	23	39	24	36	18	47	24	19	23
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-204	-188	-	-	-	-	-	-	-	-	-
Debt-free Net Working Capital (DFNWC)	1,143	1,122	-	-	-	-	-	-	-	-	-
Net Working Capital (NWC)	1,143	1,122	-	-	-	-	-	-	-	-	-
Net Nonoperating Expense (NNE)	-7.91	-3.85	8.04	10	-58	-124	-34	-6.67	-3.56	-9.43	-84
Net Nonoperating Obligations (NNO)	-1,346	-1,309	8,877	8,716	8,583	8,603	8,756	6,876	6,664	6,569	6,454
Total Depreciation and Amortization (D&A)	0.34	-0.23	242	253	257	261	195	164	161	171	156
Debt-free, Cash-free Net Working Capital to Revenue	-31.10%	-29.90%	-	-	-	-	-	-	-	-	-
Debt-free Net Working Capital to Revenue	174.49%	178.71%	-	-	-	-	-	-	-	-	-
Net Working Capital to Revenue	174.49%	178.71%	-	-	-	-	-	-	-	-	-
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.06)	($0.13)	$0.06	$0.02	$0.12	$0.21	$0.01	$0.13	$0.12	$0.09	$0.22
Adjusted Weighted Average Basic Shares Outstanding	203.53M	201.87M	699.07M	675.68M	699.35M	702.38M	600.90M	547.01M	547.06M	547.03M	546.84M
Adjusted Diluted Earnings per Share	($0.06)	($0.13)	$0.06	$0.02	$0.12	$0.21	$0.01	$0.13	$0.12	$0.09	$0.22
Adjusted Weighted Average Diluted Shares Outstanding	203.53M	201.87M	699.12M	676.23M	700.15M	703.27M	601.19M	547.28M	547.33M	547.29M	547.11M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	204.45M	202.89M	694.73M	699.56M	699.44M	699.29M	703.78M	547.17M	547.07M	547.05M	547.00M
Normalized Net Operating Profit after Tax (NOPAT)	-21	-30	60	36	42	36	42	46	65	50	51
Normalized NOPAT Margin	-12.06%	-18.35%	9.52%	5.81%	6.70%	5.79%	7.62%	9.28%	12.77%	10.06%	10.62%
Pre Tax Income Margin	-7.15%	-15.63%	8.61%	-0.52%	15.73%	25.04%	4.12%	11.98%	13.32%	11.00%	27.84%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.83	0.42	0.48	0.39	-0.97	1.09	1.30	0.97	1.06
NOPAT to Interest Expense	0.00	0.00	0.80	0.30	0.47	0.38	-0.38	1.30	1.29	0.95	1.05
EBIT Less CapEx to Interest Expense	0.00	0.00	0.51	-0.13	0.16	-0.09	-1.26	0.19	0.83	0.58	0.58
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.48	-0.26	0.15	-0.09	-0.67	0.41	0.81	0.56	0.58
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	275.67%	297.33%	225.60%	228.36%	310.39%	196.27%	242.08%	116.48%	112.85%
Augmented Payout Ratio	0.00%	0.00%	312.78%	368.67%	282.94%	283.66%	358.66%	198.22%	244.56%	127.69%	123.79%

Frequently Asked Questions About Healthpeak Properties' Financials

When does Healthpeak Properties's fiscal year end?

According to the most recent income statement we have on file, Healthpeak Properties' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Healthpeak Properties' net income changed over the last 9 years?

Healthpeak Properties' net income appears to be on an upward trend, with a most recent value of $267.30 million in 2024, falling from -$546.42 million in 2015. The previous period was $334.76 million in 2023. Find out what analysts predict for Healthpeak Properties in the coming months.

How has Healthpeak Properties revenue changed over the last 9 years?

Over the last 9 years, Healthpeak Properties' total revenue changed from $1.46 billion in 2015 to $2.42 billion in 2024, a change of 65.7%.

How much debt does Healthpeak Properties have?

Healthpeak Properties' total liabilities were at $10.88 billion at the end of 2024, a 24.0% increase from 2023, and a 7.0% decrease since 2015.

How much cash does Healthpeak Properties have?

In the past 9 years, Healthpeak Properties' cash and equivalents has ranged from $44.23 million in 2020 to $340.44 million in 2015, and is currently $119.82 million as of their latest financial filing in 2024.

How has Healthpeak Properties' book value per share changed over the last 9 years?

Over the last 9 years, Healthpeak Properties' book value per share changed from 20.09 in 2015 to 12.01 in 2024, a change of -40.2%.

Related Companies

This page (NYSE:DOC) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Healthpeak Properties (DOC) Financials

Frequently Asked Questions About Healthpeak Properties' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Healthpeak Properties (DOC) Financials

Annual Income Statements for Healthpeak Properties

Quarterly Income Statements for Healthpeak Properties

Annual Cash Flow Statements for Healthpeak Properties

Quarterly Cash Flow Statements for Healthpeak Properties

Annual Balance Sheets for Healthpeak Properties

Quarterly Balance Sheets for Healthpeak Properties

Annual Metrics And Ratios for Healthpeak Properties

Quarterly Metrics And Ratios for Healthpeak Properties

Frequently Asked Questions About Healthpeak Properties' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools